Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Training (INSeRT) for the Preventive Treatment of Pediatric Migraine

Award Number: R34AT013083
ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/22/2025
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Training (INSeRT) for the Preventive Treatment of Pediatric Migraine - Summary. Migraine is a highly prevalent neurological disease in children for which there remains a critical need for well-accepted, safe and effective preventive treatments to mitigate the progression toward a more chronic and costly condition. Cortical excitability is hypothesized to play a key role in maintaining the vulnerability to future migraine attacks. Neurofeedback is a mind-body approach that may facilitate one's ability to self-regulate cortical reactivity. However, neurofeedback in usual care settings is often difficult for families to access reliably, and there is a lack of outcome data specifically for pediatric migraine. In preliminary work, we found that children with migraine responded positively to a neurofeedback-assisted self-regulation treatment that integrates data from a wearable electroencephalogram (EEG) headband into content viewed on an immersive virtual reality headset ( Immersive Neurofeedback Self-Regulation Training - INSeRT). We hypothesize that using this intervention prospectively from home may be a practical and appealing approach for children to learn to self-modulate cortical excitability, thereby reducing their vulnerability to future migraine attacks. The current proposal seeks to further evaluate this idea by means of a pre-efficacy feasibility trial. Specific aims are: (1) to evaluate and hone the enrollment, retention, randomization, and outcome assessment procedures planned for a future efficacy trial of the INSeRT intervention, and (2) to determine the feasibility in children with migraine of completing the INSeRT treatment protocol. During a baseline phase, 38 participants (ages 10-16 years) diagnosed with migraine will complete patient-reported outcome measures, 4 weeks of migraine logs, and a lab-based EEG protocol designed to comprehensively evaluate baseline cortical reactivity. After completion of the baseline phase, participants will be randomized into one of two groups: (a) Immersive Neurofeedback Self-Regulation Training, or (b) a comparator group that will only view immersive imagery (without guided relaxation training or neurofeedback). Both groups will receive training on how to complete the procedures from home, following a schedule of three sessions per week (approximately 8 minutes per session) for a duration of four weeks. Participants will complete outcome measures remotely at post-treatment and again at a 3-month follow-up timepoint; the lab-based EEG protocol for assessing cortical reactivity will be repeated at the post-treatment timepoint. The primary trial endpoints comprise metrics related to intervention feasibility (i.e., treatment adherence, acceptability and tolerability) and trial feasibility (i.e., rates of enrollment and randomization, retention, and outcome measure completion). These data will inform whether further testing of this intervention approach is warranted, and if so, how to optimize parameters of the intervention and study procedures for a future successful efficacy trial. The planned work is significant as it will enhance our understanding of preventing migraine attacks through mechanism-informed mind-body treatments, potentially expanding pediatric options for reducing disease progression.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	CHILDRENS MERCY HOSPITAL	2401 GILLHAM RD	KANSAS CITY	MO	64108	JACKSON	USA	Research and Training in Complementary and Integrative Health	000	1	12/11/2025	NEW	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $753,142 )
2025	2025	CHILDRENS MERCY HOSPITAL	2401 GILLHAM RD	KANSAS CITY	MO	64108	JACKSON	USA	Research and Training in Complementary and Integrative Health	000	1	9/16/2025	NEW	$753,142
														Subtotal = $753,142

Grand Total All Awards = $753,142

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Feasibility Trial of Home-Based Immersive Neurofeedback Self-Regulation Training (INSeRT) for the Preventive Treatment of Pediatric Migraine

Award Number: R34AT013083

ORGANIZATION: CENTER FOR DRUG EVALUATION AND RESEARCH, NIH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/22/2025

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer